Pietrzak D, Luczak J, Wisniewski M
Pathogens. 2024; 13(6).
PMID: 38921745
PMC: 11206659.
DOI: 10.3390/pathogens13060447.
Nikiema A, Koala L, Unnasch T, Diendere J, Compaore J, Ouedraogo M
Parasite Epidemiol Control. 2024; 25:e00352.
PMID: 38708128
PMC: 11066673.
DOI: 10.1016/j.parepi.2024.e00352.
Ambe L, Limunga E, Mbah C, Adela N, Eric N, Ngoe M
Pathogens. 2024; 13(4).
PMID: 38668248
PMC: 11053476.
DOI: 10.3390/pathogens13040293.
Yalley A, Ahiatrogah S, Kafintu-Kwashie A, Amegatcher G, Prah D, Botwe A
Curr Issues Mol Biol. 2022; 44(10):4367-4385.
PMID: 36286015
PMC: 9601131.
DOI: 10.3390/cimb44100300.
Lagatie O, Debrah L, Debrah A, Stuyver L
Curr Res Parasitol Vector Borne Dis. 2022; 2:100100.
PMID: 36082138
PMC: 9445278.
DOI: 10.1016/j.crpvbd.2022.100100.
Update on parasitic dermatoses.
Cardoso A, Cardoso A, Talhari C, Santos M
An Bras Dermatol. 2020; 95(1):1-14.
PMID: 32001061
PMC: 7058862.
DOI: 10.1016/j.abd.2019.12.001.
Loa loa Microfilariae in Skin Snips: Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas.
Nana-Djeunga H, Fossuo-Thotchum F, Pion S, Chesnais C, Kubofcik J, Mackenzie C
Clin Infect Dis. 2019; 69(9):1628-1630.
PMID: 30861060
PMC: 6792118.
DOI: 10.1093/cid/ciz172.
Substantiating freedom from parasitic infection by combining transmission model predictions with disease surveys.
Michael E, Smith M, Katabarwa M, Byamukama E, Griswold E, Habomugisha P
Nat Commun. 2018; 9(1):4324.
PMID: 30337529
PMC: 6193962.
DOI: 10.1038/s41467-018-06657-5.
Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis.
Shirey R, Globisch D, Eubanks L, Hixon M, Janda K
ACS Infect Dis. 2018; 4(10):1423-1431.
PMID: 30141624
PMC: 6189908.
DOI: 10.1021/acsinfecdis.8b00163.
Operational Performance of the "OEPA" Ov16 ELISA Serological Assay in Mapping, Guiding Decisions to Stop Mass Drug Administration, and Posttreatment Surveillance Surveys.
Richards F, Katabarwa M, Bekele F, Tadesse Z, Mohammed A, Sauerbrey M
Am J Trop Med Hyg. 2018; 99(3):749-752.
PMID: 30014821
PMC: 6169192.
DOI: 10.4269/ajtmh.18-0341.
Diagnostics for onchocerciasis in the era of elimination.
Unnasch T, Golden A, Cama V, Cantey P
Int Health. 2018; 10(suppl_1):i20-i26.
PMID: 29471336
PMC: 5881263.
DOI: 10.1093/inthealth/ihx047.
O-5S quantitative real-time PCR: a new diagnostic tool for laboratory confirmation of human onchocerciasis.
Mekonnen S, Beissner M, Saar M, Ali S, Zeynudin A, Tesfaye K
Parasit Vectors. 2017; 10(1):451.
PMID: 28969662
PMC: 5625774.
DOI: 10.1186/s13071-017-2382-3.
Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.
Lont Y, Coffeng L, de Vlas S, Golden A, de Los Santos T, Domingo G
PLoS Negl Trop Dis. 2017; 11(1):e0005314.
PMID: 28114304
PMC: 5289624.
DOI: 10.1371/journal.pntd.0005314.
An isothermal DNA amplification method for detection of Onchocerca volvulus infection in skin biopsies.
Lagatie O, Merino M, Debrah L, Debrah A, Stuyver L
Parasit Vectors. 2016; 9(1):624.
PMID: 27906100
PMC: 5134125.
DOI: 10.1186/s13071-016-1913-7.
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.
Bottomley C, Isham V, Vivas-Martinez S, Kuesel A, Attah S, Opoku N
Parasit Vectors. 2016; 9(1):343.
PMID: 27301567
PMC: 4908809.
DOI: 10.1186/s13071-016-1605-3.
Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.
Golden A, Faulx D, Kalnoky M, Stevens E, Yokobe L, Peck R
Parasit Vectors. 2016; 9(1):338.
PMID: 27296630
PMC: 4907250.
DOI: 10.1186/s13071-016-1623-1.
Stage-specific Proteomes from Onchocerca ochengi, Sister Species of the Human River Blindness Parasite, Uncover Adaptations to a Nodular Lifestyle.
Armstrong S, Xia D, Bah G, Krishna R, Ngangyung H, LaCourse E
Mol Cell Proteomics. 2016; 15(8):2554-75.
PMID: 27226403
PMC: 4974336.
DOI: 10.1074/mcp.M115.055640.
Detection of Onchocerca volvulus in Skin Snips by Microscopy and Real-Time Polymerase Chain Reaction: Implications for Monitoring and Evaluation Activities.
Thiele E, Cama V, Lakwo T, Mekasha S, Abanyie F, Sleshi M
Am J Trop Med Hyg. 2016; 94(4):906-11.
PMID: 26880774
PMC: 4824238.
DOI: 10.4269/ajtmh.15-0695.
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus.
Golden A, Stevens E, Yokobe L, Faulx D, Kalnoky M, Peck R
PLoS Negl Trop Dis. 2016; 10(1):e0004292.
PMID: 26745374
PMC: 4706346.
DOI: 10.1371/journal.pntd.0004292.
Extracellular Onchocerca-derived small RNAs in host nodules and blood.
Quintana J, Makepeace B, Babayan S, Ivens A, Pfarr K, Blaxter M
Parasit Vectors. 2015; 8:58.
PMID: 25623184
PMC: 4316651.
DOI: 10.1186/s13071-015-0656-1.